Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $523,848 | $509,790 | $489,735 | $470,252 |
| % Growth | 2.8% | 4.1% | 4.1% | – |
| Cost of Goods Sold | $435,475 | $415,741 | $410,816 | $386,412 |
| Gross Profit | $88,373 | $94,049 | $78,919 | $83,840 |
| % Margin | 16.9% | 18.4% | 16.1% | 17.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $38,592 | $40,259 | $38,117 | $44,173 |
| SG&A Expenses | $38,592 | $38,894 | $38,117 | $44,173 |
| Sales & Mktg Exp. | $0 | -$1,365 | $0 | $0 |
| Other Operating Expenses | -$8,775 | $515 | -$722 | -$5,595 |
| Operating Expenses | $29,817 | $39,409 | $37,395 | $38,578 |
| Operating Income | $58,556 | $54,640 | $41,524 | $45,262 |
| % Margin | 11.2% | 10.7% | 8.5% | 9.6% |
| Other Income/Exp. Net | -$12,369 | -$13,430 | -$11,570 | -$9,152 |
| Pre-Tax Income | $46,187 | $41,210 | $29,954 | $36,110 |
| Tax Expense | $14,034 | $4,185 | $10,296 | $15,891 |
| Net Income | $31,400 | $36,675 | $19,453 | $19,727 |
| % Margin | 6% | 7.2% | 4% | 4.2% |
| EPS | 0.67 | 0.79 | 0.42 | 0.43 |
| % Growth | -15.2% | 88.1% | -2.3% | – |
| EPS Diluted | 0.66 | 0.77 | 0.42 | 0.42 |
| Weighted Avg Shares Out | 46,897 | 46,683 | 46,334 | 46,009 |
| Weighted Avg Shares Out Dil | 47,685 | 47,523 | 46,813 | 46,690 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $12,369 | $13,430 | $11,570 | $9,152 |
| Depreciation & Amortization | $14,953 | $15,784 | $17,161 | $18,516 |
| EBITDA | $73,273 | $70,424 | $58,685 | $63,778 |
| % Margin | 14% | 13.8% | 12% | 13.6% |